Intravenous recombinant tissue plasminogen activator (r TPA) was endorsed by ministry of health after a study that was conducted to assess the obstacles regarding its availability, and this resulted in 5 times increase in thrombolysis in Ain Shams University stroke centers [3]. The gene discussed is PLAT; the disease is Stroke.